Cephalosporin Market Expected to Reach $4,980 Million by 2023
The global cephalosporin market was valued at $3,136 million in 2016, and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023, according to the new report published by Allied Market Research. The third-generation cephalosporin segment held around one-third share of the total market in 2016.
View full press release